Skip to content
Home
About
Our Strategy
Annual report and impact
Meet the team
Partnerships, memberships and affiliations
Our Story
News & Updates
Contact
Shop
Make a donation
Home
About
Our Strategy
SMA UK’s 40th Anniversay
Meet the team
Annual report and impact
Partnerships, memberships and affiliations
Our Story
Join our team
Support & Information
About SMA
Recently Diagnosed with SMA
SMA Care UK
Support for you
SMA UK grants for the Community
Rarer Forms of SMA
Our Information Service
Professional Training and Upskilling
Treatments & Research
SMA Drug Pipeline
Access to Treatment
Nusinersen (Spinraza)
Risdiplam (Evrysdi)
Zolgensma (Onasemnogene Abeparvovec)
Drugs Currently Being Tested in Clinical Trials
Measures Used to Assess a Drug’s Effectiveness
Clinical, Innovative, & Basic Research
Treatment Approaches
Advocacy & Campaigning
Newborn Screening for SMA
Advocacy for Access to Treatments
National Strategies, Campaigns and Consultations
Priorities for Adults
SMA Awareness
SMA Care UK
For Patients and Families
For Healthcare Professionals
Living with SMA
Children (0-12 years) Living with SMA
Teenagers (13-17 years) Living With SMA
Adults Living with SMA
Family and Friends
Connect with the Community
Community Networks
Community Podcasts & Videos
Community Voices
Community Events
Other Ways to Connect
Our Newsletter
Support SMA UK
Donate
Fundraise for Us
Become a Corporate Supporter
In Memory
Fundraising Tips & Resources
How your donation makes a difference
Be Inspired by Others
Contact the Fundraising Team
News
Shop
Contact
Make a donation
Support & Information
Support & Information
About SMA
Recently Diagnosed with SMA
Support For You
FlexiGrants
SMArt Moves
Rarer Forms of SMA
Support For Professionals
Our Information Service
